Mankind Pharma shares fall 2.5% after BSV acquisition
Mankind Pharma Share Price: Mankind Pharma shares dropped by 2.5% following the announcement of a Rs 13,630 crore acquisition of Bharat Serums and Vaccines (BSV). The acquisition aims to strengthen Mankind\’s position in women\’s health and fertility drugs. BSV reported strong revenue growth in FY24, with a notable presence in IVF and critical care segments.